BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jin MZ, Han RR, Qiu GZ, Ju XC, Lou G, Jin WL. Organoids: An intermediate modeling platform in precision oncology. Cancer Lett 2018;414:174-80. [PMID: 29174804 DOI: 10.1016/j.canlet.2017.11.021] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Higashi Y, Matsumoto K, Saitoh H, Shiro A, Ma Y, Laird M, Chinnathambi S, Birault A, Doan TLH, Yasuda R, Tajima T, Kawachi T, Tamanoi F. Iodine containing porous organosilica nanoparticles trigger tumor spheroids destruction upon monochromatic X-ray irradiation: DNA breaks and K-edge energy X-ray. Sci Rep 2021;11:14192. [PMID: 34262055 DOI: 10.1038/s41598-021-93429-9] [Reference Citation Analysis]
2 Cattin S, Ramont L, Rüegg C. Characterization and In Vivo Validation of a Three-Dimensional Multi-Cellular Culture Model to Study Heterotypic Interactions in Colorectal Cancer Cell Growth, Invasion and Metastasis. Front Bioeng Biotechnol 2018;6:97. [PMID: 30065926 DOI: 10.3389/fbioe.2018.00097] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
3 Paolillo M, Comincini S, Schinelli S. In Vitro Glioblastoma Models: A Journey into the Third Dimension. Cancers (Basel) 2021;13:2449. [PMID: 34070023 DOI: 10.3390/cancers13102449] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Tamanoi F. Recent excitements in the study of the CAM assay. Enzymes 2019;46:1-9. [PMID: 31727271 DOI: 10.1016/bs.enz.2019.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Xu Y, Jin MZ, Yang ZY, Jin WL. Microglia in neurodegenerative diseases. Neural Regen Res 2021;16:270-80. [PMID: 32859774 DOI: 10.4103/1673-5374.290881] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
6 Laranga R, Duchi S, Ibrahim T, Guerrieri AN, Donati DM, Lucarelli E. Trends in Bone Metastasis Modeling. Cancers (Basel) 2020;12:E2315. [PMID: 32824479 DOI: 10.3390/cancers12082315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Vu BT, Shahin SA, Croissant J, Fatieiev Y, Matsumoto K, Le-Hoang Doan T, Yik T, Simargi S, Conteras A, Ratliff L, Jimenez CM, Raehm L, Khashab N, Durand JO, Glackin C, Tamanoi F. Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer. Sci Rep 2018;8:8524. [PMID: 29867159 DOI: 10.1038/s41598-018-25573-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 11.3] [Reference Citation Analysis]
8 Saglam-metiner P, Gulce-iz S, Biray-avci C. Bioengineering-inspired three-dimensional culture systems: Organoids to create tumor microenvironment. Gene 2019;686:203-12. [DOI: 10.1016/j.gene.2018.11.058] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 11.3] [Reference Citation Analysis]
9 Mohan SC, Lee TY, Giuliano AE, Cui X. Current Status of Breast Organoid Models. Front Bioeng Biotechnol 2021;9:745943. [PMID: 34805107 DOI: 10.3389/fbioe.2021.745943] [Reference Citation Analysis]
10 Fan Z, Gao Y, Zhang W, Yang G, Liu P, Xu L, Wang J, Yan Z, Han H, Liu R, Shu M. METTL3/IGF2BP1/CD47 contributes to the sublethal heat treatment induced mesenchymal transition in HCC. Biochem Biophys Res Commun 2021;546:169-77. [PMID: 33582561 DOI: 10.1016/j.bbrc.2021.01.085] [Reference Citation Analysis]
11 Ma YS, Yang XL, Xin R, Wu TM, Shi Y, Dan Zhang D, Wang HM, Wang PY, Liu JB, Fu D. The power and the promise of organoid models for cancer precision medicine with next-generation functional diagnostics and pharmaceutical exploitation. Transl Oncol 2021;14:101126. [PMID: 34020369 DOI: 10.1016/j.tranon.2021.101126] [Reference Citation Analysis]
12 Srisongkram T, Weerapreeyakul N, Thumanu K. Evaluation of Melanoma (SK-MEL-2) Cell Growth between Three-Dimensional (3D) and Two-Dimensional (2D) Cell Cultures with Fourier Transform Infrared (FTIR) Microspectroscopy. Int J Mol Sci 2020;21:E4141. [PMID: 32531986 DOI: 10.3390/ijms21114141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Yao L, Zao XL, Pan XF, Zhang HG, Wang FJ, Qiao PF. Application of tumoroids derived from advanced colorectal cancer patients to predict individual response to chemotherapy. J Chemother 2022;:1-13. [PMID: 35285783 DOI: 10.1080/1120009X.2022.2045827] [Reference Citation Analysis]
14 Finch A, Solomou G, Wykes V, Pohl U, Bardella C, Watts C. Advances in Research of Adult Gliomas. Int J Mol Sci 2021;22:E924. [PMID: 33477674 DOI: 10.3390/ijms22020924] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Camargo S, Shamis Y, Assis A, Mitrani E. An in vivo Like Micro-Carcinoma Model. Front Oncol 2019;9:410. [PMID: 31192122 DOI: 10.3389/fonc.2019.00410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Pernik MN, Bird CE, Traylor JI, Shi DD, Richardson TE, McBrayer SK, Abdullah KG. Patient-Derived Cancer Organoids for Precision Oncology Treatment. J Pers Med 2021;11:423. [PMID: 34067714 DOI: 10.3390/jpm11050423] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Komatsu A, Matsumoto K, Saito T, Muto M, Tamanoi F. Patient Derived Chicken Egg Tumor Model (PDcE Model): Current Status and Critical Issues. Cells 2019;8:E440. [PMID: 31083409 DOI: 10.3390/cells8050440] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
18 Banda M, McKim KL, Myers MB, Inoue M, Parsons BL. Outgrowth of erlotinib-resistant subpopulations recapitulated in patient-derived lung tumor spheroids and organoids. PLoS One 2020;15:e0238862. [PMID: 32898185 DOI: 10.1371/journal.pone.0238862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Liu HD, Xia BR, Jin MZ, Lou G. Organoid of ovarian cancer: genomic analysis and drug screening. Clin Transl Oncol 2020;22:1240-51. [PMID: 31939100 DOI: 10.1007/s12094-019-02276-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
20 Cavero I, Guillon J, Holzgrefe HH. Human organotypic bioconstructs from organ-on-chip devices for human-predictive biological insights on drug candidates. Expert Opinion on Drug Safety 2019;18:651-77. [DOI: 10.1080/14740338.2019.1634689] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
21 Yang F, Wang H, Liu X, Ge N, Guo J, Wang S, Song X, Cao L, Sun S. EUS-guided fine-needle technique-derived cancer organoids: A tailored "Shennong deity" for every patient with cancer. Endosc Ultrasound. 2019;8:73-75. [PMID: 31006704 DOI: 10.4103/eus.eus_13_19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
22 Liang T, Tao Q, Guan R, Cao G, Shen H, Liu Z, Xia Q. Antioxidant and Antiproliferative Activities of Cyanidin-3-O-Glucoside (C3G) Liposome in Caco-2 Cells Cultivated in 2D and 3D Cell Culture Models. J Food Sci 2019;84:1638-45. [PMID: 31141616 DOI: 10.1111/1750-3841.14629] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Yang Z, Xu H, Zhao X. Designer Self-Assembling Peptide Hydrogels to Engineer 3D Cell Microenvironments for Cell Constructs Formation and Precise Oncology Remodeling in Ovarian Cancer. Adv Sci (Weinh) 2020;7:1903718. [PMID: 32382486 DOI: 10.1002/advs.201903718] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 23.5] [Reference Citation Analysis]
24 Hakuno SK, Michiels E, Kuhlemaijer EB, Rooman I, Hawinkels LJAC, Slingerland M. Multicellular Modelling of Difficult-to-Treat Gastrointestinal Cancers: Current Possibilities and Challenges. Int J Mol Sci 2022;23:3147. [PMID: 35328567 DOI: 10.3390/ijms23063147] [Reference Citation Analysis]
25 O'connell L, Winter DC. Organoids: Past Learning and Future Directions. Stem Cells and Development 2020;29:281-9. [DOI: 10.1089/scd.2019.0227] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
26 Zhao X, Fu J, Hu B, Chen L, Wang J, Fang J, Ge C, Lin H, Pan K, Fu L, Wang L, Du J, Xu W. Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer. Front Cell Dev Biol 2021;9:639111. [PMID: 34055773 DOI: 10.3389/fcell.2021.639111] [Reference Citation Analysis]
27 Luo Z, Zhou X, Mandal K, He N, Wennerberg W, Qu M, Jiang X, Sun W, Khademhosseini A. Reconstructing the tumor architecture into organoids. Adv Drug Deliv Rev 2021;176:113839. [PMID: 34153370 DOI: 10.1016/j.addr.2021.113839] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
28 Pyo DH, Hong HK, Lee WY, Cho YB. Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line. Cancer Biol Ther 2020;21:495-502. [PMID: 32208894 DOI: 10.1080/15384047.2020.1738907] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Yang C, Xia BR, Zhang ZC, Zhang YJ, Lou G, Jin WL. Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant. Front Immunol 2020;11:577869. [PMID: 33123161 DOI: 10.3389/fimmu.2020.577869] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
30 de Jongh D, Massey EK, Berishvili E, Fonseca LM, Lebreton F, Bellofatto K, Bignard J, Seissler J, Buerck LW, Honarpisheh M, Zhang Y, Lei Y, Pehl M, Follenzi A, Olgasi C, Cucci A, Borsotti C, Assanelli S, Piemonti L, Citro A, Pellegrini S, Pignatelli C, Campo F, Thaunat O, Cronin AJ, Mey D, Parisotto C, Rossi G, Kugelmeier P, Wolint P, Mühlemann M, Pal-kutas K, Cavallaro M, Götz J, Müller J, Bunnik EM; the VANGUARD consortium. Organoids: a systematic review of ethical issues. Stem Cell Res Ther 2022;13. [DOI: 10.1186/s13287-022-02950-9] [Reference Citation Analysis]
31 Abugomaa A, Elbadawy M. Patient-derived organoid analysis of drug resistance in precision medicine: is there a value? Expert Review of Precision Medicine and Drug Development 2020;5:1-5. [DOI: 10.1080/23808993.2020.1715794] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
32 Matsumoto K, Le Hoang Doan T, Mai NXD, Nakai K, Komatsu A, Tamanoi F. Anticancer Drug Delivery Capability of Biodegradable PMO in the Chicken Egg Tumor Model. Mesoporous Silica-based Nanomaterials and Biomedical Applications, Part B. Elsevier; 2018. pp. 103-16. [DOI: 10.1016/bs.enz.2018.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Lühr A, von Neubeck C, Krause M, Troost EGC. Relative biological effectiveness in proton beam therapy - Current knowledge and future challenges. Clin Transl Radiat Oncol 2018;9:35-41. [PMID: 29594249 DOI: 10.1016/j.ctro.2018.01.006] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 17.3] [Reference Citation Analysis]
34 Li XY, Pi YN, Chen Y, Zhu Q, Xia BR. Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy. Front Oncol 2022;12:894744. [PMID: 35756670 DOI: 10.3389/fonc.2022.894744] [Reference Citation Analysis]
35 Xie H, Wang W, Xia B, Jin W, Lou G. Therapeutic applications of PARP inhibitors in ovarian cancer. Biomed Pharmacother 2020;127:110204. [PMID: 32422564 DOI: 10.1016/j.biopha.2020.110204] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
36 Lin KC, Ting LL, Chang CL, Lu LS, Lee HL, Hsu FC, Chiou JF, Wang PY, Burnouf T, Ho DC, Yang KC, Chen CY, Chen CH, Wu CZ, Chen YJ. Ex Vivo Expanded Circulating Tumor Cells for Clinical Anti-Cancer Drug Prediction in Patients with Head and Neck Cancer. Cancers (Basel) 2021;13:6076. [PMID: 34885184 DOI: 10.3390/cancers13236076] [Reference Citation Analysis]
37 Tamanoi F, Matsumoto K, Doan TLH, Shiro A, Saitoh H. Studies on the Exposure of Gadolinium Containing Nanoparticles with Monochromatic X-rays Drive Advances in Radiation Therapy. Nanomaterials (Basel) 2020;10:E1341. [PMID: 32660093 DOI: 10.3390/nano10071341] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
38 Yang C, Xia BR, Jin WL, Lou G. Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model. Cancer Cell Int 2019;19:341. [PMID: 31866766 DOI: 10.1186/s12935-019-1067-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
39 Seidlitz T, Koo BK, Stange DE. Gastric organoids-an in vitro model system for the study of gastric development and road to personalized medicine. Cell Death Differ 2021;28:68-83. [PMID: 33223522 DOI: 10.1038/s41418-020-00662-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
40 O'Connell L, Winter DC, Aherne CM. The Role of Organoids as a Novel Platform for Modeling of Inflammatory Bowel Disease. Front Pediatr 2021;9:624045. [PMID: 33681101 DOI: 10.3389/fped.2021.624045] [Reference Citation Analysis]